Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Also, market is so hung up on pharma stocks, recovery stocks, gold, silver and copper in metals that Graphite is under the radar. I have a feeling a some of profits from other metal stocks will find its way into TGR as investors try to diversify and FOMO kicks in when the price starts going up. low free float+FOMO+ diversifying should shore the stock price up in the short to medium term
25.5 Mt would be worth a lot more than £16m imo for the quality of graphite they produce. Graphene is worth a lot more once they start producing. When they start producing Graphene and people catchup on the potential of producing 10k graphene per day, even if there is a placing , it would be in multiples of £s not in pence.Also, sand, the byproduct has not been valuated at at at the moment and should be worth a few £m. I doubt if there would be a placing at all moving forward. Current value for TGR I hold as per my calculation is north of £1 at the moment imo and I will not be trading these. Will sell if I get a target price of £4 eventually or if I find the management to be slipping consistantly on the deadlines, which I doubt as they have skin in the game which is a huge plus. Once it crosses £1, I doubt it will ever see a value in pence. AIMHO DYOR
good find Korda. It looks similar to congestion charges website where I end up paying fines after drifting into zone1 in london
Yes, old news, but the link has info that odx have a direct marketing team in India
Because the concrete orders for the vaccine are not done yet
True enteleon, having their marketing team in India deffo helps
'Once past this final clearance, the company will use its direct sales team in India to establish commercial roll-out.'
Source:
https://www.heraldscotland.com/business_hq/18557746.covid-19-test-omega-diagnostics-approved-india/
Poonawalla informed that the Serum Institute of India is in the process of applying for emergency use authorization of their COVID-19 vaccine 'COVISHIELD' in the next two weeks.
He also said, "As of now, we don't have anything in writing with the govt of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July, 2021."
Source:
https://zeenews.india.com/india/serum-institute-of-india-ceo-adar-poonawalla-amazed-at-pm-narendra-modis-knowledge-about-covid-19-vaccine-production-2327288.html
Imagine the amount of antibody testing that would be done before and after the vaccine. Staggering numbers!
My reason for being heavily invested in ODX is more for the higher volume high margin Indian orders more than the UK orders
https://timesofindia.indiatimes.com/india/covid-19-pm-modi-to-visit-serum-institute-of-india-in-pune-on-nov-28/articleshow/79424724.cms
Ambassadors and envoys of 100 countries to visit Indian partner of AstraZeneca and the Oxford University for Covid-19 vaccine on December 4th.
iphonetrader, Read the following and you will realize that your concerns were misplaced(unless ofcorrse it was not an innocent question and was a subtle deramp)
https://news.sky.com/story/covid-19-astrazeneca-to-run-extra-trial-of-vaccine-developed-with-oxford-university-12143150
"
It's also possible that it might not be a significant hurdle in the UK (American regulators are another matter. It is notable that most of this criticism of a European effort is coming from the US).
The full data from the Oxford vaccine trial has not been published, so it's hard to come to firm conclusions. But scientists are very confident that this vaccine will work and that some version of it will arrive in the UK before too long. Nothing in this pandemic is ever certain, but this latest news won't have shaken that optimism.
"
http://ajhs.biomedpress.org/index.php/ajhs/article/view/478
Total covid-19 antibody testing was done by the technology of electrochemiluminescence immunoassay (ECLIA), and that for IgG was done by enzyme-linked immunosorbent assay (ELISA).
The approved commercial kits for ELISA include the COVID-19 IgG ELISA Kit (Omega Diagnostics, UK) and ErbaLisa® COVID-19 IgG (Calbiotech Inc. USA).
Conclusions
Under-reporting of data across age groups can greatly impact the outcome of social distancing and other pandemic control measures. A seroprevalence study to a great extent can aid in assessing epidemiology surveillance, and when data across different age group is made available, informed choices behind easing lockdown strategies becomes easier.
https://vimeo.com/440893644
Chilli farming
‘List’ not lost. Typing on my mobile + fat fingers sorry
If we get a contract from India where odx is already on the approved suppliers lost, it would probably be a blessing if we do not get the government contract imo as we can sell for much higher prices.
Anyone got updates on the India side of things?
Odx is now a substantial part of my portfolio and am personally invested more for bigger margins made from selling to overseas buyers than the government.
Each of us in this with our own angle, but the common denominator is our desire for this to succeed. My first post, but have been a silent spectator on this board.This board has been very useful as a starting point for researching this stock.
Gentle appeal, would be great if all of us concentrate on sharing knowledge useful to holders and potential investors and not get into 50 percent - 100 percent debates arguments which do not add any value to the board or to the stock imo